Stock NWRN NEWRON PHARMACEUTICALS S.P.A.
Add to a list
To use this feature you must be a member
Log inSign up

Analyst Reco. Newron Pharmaceuticals S.p.A.

Equities

NWRN

IT0004147952

Delayed Swiss Exchange
Other stock markets
 03:57:23 2024-05-03 am EDT 		5-day change 1st Jan Change
8.6 CHF +3.49% Intraday chart for Newron Pharmaceuticals S.p.A. +22.86% +73.74%
Apr. 30 Newron Pharmaceuticals S.p.A. Announces Positive Top-line Results From Potentially Pivotal Phase II/III Study 008A With Evenamide in Schizophrenia Patients CI
Apr. 17 Newron Pharmaceuticals Appoints Margarita Chavez as Independent Board Member CI

Analyst Reco.

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Swiss Equities Edge Higher as Markets Continue to Weigh Rate Cut Outlook
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NWRN Stock
  4. News Newron Pharmaceuticals S.p.A.
  5. Analyst Reco.